LEXICON PHARMACEUTICALS, INC. Gain (Loss) on Investments
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Gain (Loss) on Investments of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-11.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2013-03-11
- LEXICON PHARMACEUTICALS, INC. gain (loss) on investments for the quarter ending 2011-12-31 was $0.00.
- LEXICON PHARMACEUTICALS, INC. gain (loss) on investments for the quarter ending 2011-09-30 was $0.00.
- LEXICON PHARMACEUTICALS, INC. gain (loss) on investments for the quarter ending 2011-06-30 was $0.00, a 100.00% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. gain (loss) on investments for the quarter ending 2010-12-31 was $0.00.
- LEXICON PHARMACEUTICALS, INC. gain (loss) on investments for fiscal 2012 was $0.00.
- LEXICON PHARMACEUTICALS, INC. gain (loss) on investments for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- LEXICON PHARMACEUTICALS, INC. gain (loss) on investments for fiscal 2010 was $141.00K, a 87.98% decline from fiscal 2009.
- LEXICON PHARMACEUTICALS, INC. gain (loss) on investments for fiscal 2009 was $1.17M.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-03-11 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $0.00 derived: sum of 2 quarters · filed 2013-03-11 | $0.00 derived: sum of 3 quarters · filed 2013-03-11 | $0.00 10-K · filed 2013-03-11 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-01 | $0.00 derived: sum of 2 quarters · filed 2011-11-01 | $0.00 10-Q · filed 2011-11-01 | |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-09 | $0.00 10-Q · filed 2011-08-09 | ||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $0.00 derived: sum of 2 quarters · filed 2013-03-11 | $53.00K derived: sum of 3 quarters · filed 2013-03-11 | $141.00K 10-K · filed 2013-03-11 |
| 2010-09-30 | $0.00 10-Q · filed 2011-11-01 | $53.00K derived: sum of 2 quarters · filed 2011-11-01 | $141.00K 10-Q · filed 2011-11-01 | |
| 2010-06-30 | $53.00K 10-Q · filed 2011-08-09 | $141.00K 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $1.17M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |